Dr. Steven Fallon is a Wyomissing, Pennsylvania based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1075 Berkshire Blvd, Suite 800, Wyomissing. Patients can reach him at 610-374-4093.
Dr. Steven Fallon deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Steven Fallon speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Steven Fallon
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DMD
Accepts Medicare Assignment:
May Accept
Practice Address:
1075 Berkshire Blvd, Suite 800, Wyomissing, Pennsylvania, 19610-1264
Phone:
610-374-4093
Fax:
610-375-6454
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
9133154560
Enrollment ID:
I20110524000422
NPI Number:
1114918497
NPI Enumeration Date:
04 Nov, 2005
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1075 Berkshire Blvd, Suite 800 Wyomissing, Pennsylvania
Zip:
19610-1264
Phone Number:
610-374-4093
Fax Number:
610-375-6454
Patients can reach Dr. Steven Fallon at 1075 Berkshire Blvd, Suite 800, Wyomissing, Pennsylvania or can call to book an appointment on 610-374-4093. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.